Generate a tailored SOP for Dr. Anette Gabriele Ziegler. Improve your application with a focused, well-structured draft.
Professor Ziegler focuses primarily on understanding the natural history of type 1 diabetes in humans, as well as identifying mechanisms and predictive markers of the disease. Her research aims to translate findings into trials that prevent type 1 diabetes. A major area of focus is the elucidation of the impact of gestational diabetes and maternal hyperglycemia on the long-term risk of obesity and type 2 diabetes in mothers and their offspring. She studied medicine at LMU Munich and obtained her doctorate there. Following her education, she worked as a research fellow at the Joslin Diabetes Center in Boston, USA, from 1987 to 1989. Professor Ziegler received the Heisenberg Career Development Award from the German Research Foundation in 1993 and is certified by the German medical board in internal medicine and endocrinology. She became an adjunct professor at LMU Munich in 1998 and served as the Director of the Department of Endocrinology at Klinikum Schwabing in Munich from 2007 to 2009. In 2010, she was appointed Chair of Diabetes and Gestational Diabetes at TUM, where she also became the Director of the newly founded Institute for Diabetes Research at Helmholtz Zentrum München. In 2017, she was President of the Immunology Diabetes Society and is involved in leading international studies for the prevention of autoimmune diabetes.
Technical University of Munich • Munich, Germany
Appointed Chair focusing on diabetes and its implications in gestational cases.
Institute for Diabetes Research, Helmholtz Zentrum München • Munich, Germany
Overseeing research initiatives focused on diabetes.
Department of Endocrinology, Klinikum Schwabing • Munich, Germany
Managed the department focusing on endocrine disorders.